This Week in Nephrology — Jun 14, 2026

Welcome to This Week in Nephrology. This week we're covering 7 notable papers spanning advances in kidney transplantation and new perspectives on chronic kidney disease, from risk factors to new therapeutics and diagnostics. Let's dive in.

We begin…

This week's papers: 1. Genetic Screening of Patients With Inherited Fanconi Syndrome. — Kidney international reports 2026 2. Limitations of Serum Bicarbonate as a Criterion for Metabolic Acidosis in CKD: Implications for Clinical Trials. — Journal of the American Society of Nephrology : JASN 2026 3. Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in Chronic Kidney Disease: An East Asian Cohort Study. — Clinical journal of the American Society of Nephrology : CJASN 2026 4. Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial. — Clinical journal of the American Society of Nephrology : CJASN 2026 5. Improving diagnostic performance of kidney allograft rejection with a model combining relative fraction and absolute copies of donor-derived cell-free DNA - re… — American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2026 6. Cyclosporin a- versus tacrolimus-specific lesions in calcineurin inhibitor nephrotoxicity. — Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026 7. Discovery of Endothelial Cell Antibodies Associated with Pediatric and Adult Kidney Allograft Rejection and Assessment of a non-HLA Antibody Assay. — American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2026 8. Evaluation of the Association between Age, Sex and d-Amino Acid-Based Estimation of Glomerular Filtration Rate. — Clinical journal of the American Society of Nephrology : CJASN 2026 9. Treatment potential of oral small-molecule GLP-1 receptor agonists. — Lancet (London, England) 2026

Listen at https://audioscholar.cc/episode/ekwmdbhrhh